Medical Advisor for Innovation As a Medical Advisor for HistoSonics, Jeff Geschwind, MD helps pioneer a groundbreaking, non-invasive therapy for liver cancer. His expertise is vital in developing technology that destroys tumors without a single incision. https://www.academia.edu/143398007/Targeting_Tumor_Glycolysis_A_Promising_Frontier_in_Cancer_Therapy